NY State Senate Bill S719

Archive: Last Bill Status - In Senate Committee Insurance Committee

Introduced
In Committee
On Floor Calendar
- Passed Senate
- Passed Assembly
Delivered to Governor
Signed/Vetoed by Governor

Your Voice

Please enter your contact information

First Name *

Last Name *

Email Address *

A valid email address is required.

Home address search or enter your address manually *

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Leave this field blank

Actions

view actions (2)

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 08, 2020	referred to insurance
Jan 09, 2019	referred to insurance

Co-Sponsors

view additional co-sponsors

S719 (ACTIVE) - Details

See Assembly Version of this Bill:: A2817
Current Committee:: Senate Insurance
Law Section:: Insurance Law
Laws Affected:: Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in Other Legislative Sessions:: 2015-2016: S7219, A10137
2017-2018: S3148, A2646

S719 (ACTIVE) - Summary

Relates to insurance coverage of in vitro fertilization and other fertility preservation treatments.

S719 (ACTIVE) - Sponsor Memo

 
BILL NUMBER: S719

SPONSOR: SAVINO
 
TITLE OF BILL:  An act to amend the insurance law, in relation to
insurance coverage of in vitro fertilization and other fertility preser-
vation treatments

 
PURPOSE:

To require health insurance policies to provide coverage for in-vitro
fertilization

 
SUMMARY OF PROVISIONS:

Sections one of the bill amends section 3216 of the Ins. L. to require
that individual policies provide coverage for (1) in-vitro fertilization
used in the treatment of infertility, and (2) fertility preservation
services, regardless of length or quality of life, medical dependency,
disability, or personal characteristics.

Section two of the bill would amend section 3221 of the Ins. L. to

require that group policies provide coverage for (1) in-vitro fertiliza-
tion used in the treatment of infertility, and (2) fertility preserva-
tion services, regardless of length or quality of life, medical depend-
ency, disability, or personal characteristics.

Section three of the bill would amend Section 4303 of the Ins. L. to
require that policies issued by a medical expense indemnity corporation,
hospital service corporation, or health service corporation provide
coverage for (1) in-vitro fertilization used in the treatment of infer-
tility, and (2) fertility preservation services, regardless of length or
quality of life, medical dependency, disability, or personal character-
istics.

Section four of the bill amends subparagraph c of paragraph 6 of
subsection k of section 3221 of the insurance law to repeal discrimina-
tory age restrictions and provisions exempting in-vitro fertilization,
gamete intrafallopian tube transfers or zygote intrafallopian tube
transfers from coverage requirements for group or blanket accident and
health insurance plans.

Section five of the bill amends paragraph 3 of subsection S of section
4303 of the insurance law to apply the same requirements to benefits
provided by a medical expense indemnity corporation, hospital service
corporation, or health service corporation.

Section six of the bill provides the effective date of the bill.

 
EXISTING LAW:

Currently, New York requires coverage of some infertility treatments in
the commercial market place for women between the ages of 21 and 44,
However, current law does not require coverage for in-vitro fertilize-
tion (IVF), or fertility preservation.

 
JUSTIFICATION:

It is estimated that one in eight individuals or couples have trouble
getting pregnant or sustaining pregnancy. While family building options
do exist for people affected by infertility, these options are often
cost-prohibitive, with 671 of individuals or couples reporting spending
at least $10,000. High costs present a major bather to medical treat-
ment; nearly half of all individuals affected by infertility lack insur-
ance coverage necessary for fertility treatment.

The rapid advancement of medical technology in the past 20 years estab-
lished in-vitro fertilization as the safest and most effective form of
fertility treatment. Compared to treatments presently covered under New
York state law, such as ovulation induction or ovulation enhancement,
in-vitro fertilization results in fewer pregnancy complications and
high-risk births. Several states, including Massachusetts, Rhode Island,
New Jersey, Maryland, Illinois, Arkansas, Hawaii, and Connecticut, have
already enacted laws requiring insurers to cover in-vitro fertilization.
These states experience lower rates of multiple births and associated
neo-natal and pediatric care costs. This legislation has the potential
to save New York millions of dollars in long-term health care costs,
since patients would no longer be forced to rely on higher risk medical
procedures.

Under current law, New York requires insurers to provide coverage for
some diagnostic and treatment procedures for infertility. However, these
requirements do not extend to in-vitro fertilization. This bill would
update the existing law to reflect advances in modern medical technolo-
gy, requiring coverage for in-vitro fertilization to expand access to
this procedure and enable patients and their physicians to choose the
best course of treatment for infertility. It would also provide a clear
definition of infertility and ensure that cancer patients whose ability
to conceive has been compromised by chemotherapy, radiation, surgery, or
other medical procedures have fair access to fertility preservation
methods. Lastly, this bill includes anti-discrimination protections for
patients eligible for in-vitro fertilization, as required by the Afford-
able Care Act.

 
LEGISLATIVE HISTORY:

2018 Session- S.3148 - referred to Insurance, same as bill passed Assem-
bly
2017 Session- S.3148 - referred to Insurance, same as bill passed Assem-
bly
2016 Session- S.7219 referred to Insurance; same as bill reported from
Assembly Insurance and Codes, died in Rules.

 
FISCAL IMPLICATIONS:

None.

 
EFFECTIVE DATE:
This act would take effect on the first day of January next succeeding
the date on which it shall have become a law and shall apply to all
policies issued, renewed, altered or modified on or after such date.

S719 (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                   719

                       2019-2020 Regular Sessions

                            I N  S E N A T E

                               (PREFILED)

                             January 9, 2019
                               ___________

Introduced  by  Sens.  SAVINO, BIAGGI -- read twice and ordered printed,
  and when printed to be committed to the Committee on Insurance

AN ACT to amend the insurance law, in relation to insurance coverage  of
  in vitro fertilization and other fertility preservation treatments

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Paragraph 13 of subsection  (i)  of  section  3216  of  the
insurance  law is amended by adding three new subparagraphs (C), (D) and
(E) to read as follows:
  (C) EVERY POLICY DELIVERED OR ISSUED FOR DELIVERY IN THIS  STATE  THAT
PROVIDES  COVERAGE  FOR HOSPITAL, SURGICAL OR MEDICAL CARE SHALL PROVIDE
COVERAGE FOR:
  (I) IN VITRO FERTILIZATION USED IN THE TREATMENT OF INFERTILITY; AND
  (II) STANDARD FERTILITY PRESERVATION SERVICES WHEN A NECESSARY MEDICAL
TREATMENT MAY DIRECTLY OR INDIRECTLY CAUSE IATROGENIC INFERTILITY  TO  A
COVERED PERSON.
  (D)  (I)  FOR  THE  PURPOSES  OF  SUBPARAGRAPH  (C) OF THIS PARAGRAPH,
"INFERTILITY" MEANS A DISEASE OR CONDITION CHARACTERIZED BY THE INCAPAC-
ITY TO IMPREGNATE ANOTHER PERSON OR TO CONCEIVE, AS DIAGNOSED OR  DETER-
MINED (I) BY A PHYSICIAN LICENSED TO PRACTICE MEDICINE IN THIS STATE, OR
(II)  BY  THE  FAILURE  TO  ESTABLISH  A CLINICAL PREGNANCY AFTER TWELVE
MONTHS OF REGULAR, UNPROTECTED SEXUAL INTERCOURSE, OR AFTER  SIX  MONTHS
OF REGULAR, UNPROTECTED SEXUAL INTERCOURSE IN THE CASE OF A FEMALE THIR-
TY-FIVE YEARS OF AGE OR OLDER.
  (II)  FOR  THE PURPOSES OF SUBPARAGRAPH (C) OF THIS PARAGRAPH, "IATRO-
GENIC INFERTILITY" MEANS AN IMPAIRMENT OF FERTILITY  BY  SURGERY,  RADI-
ATION,  CHEMOTHERAPY  OR  OTHER MEDICAL TREATMENT AFFECTING REPRODUCTIVE
ORGANS OR PROCESSES.
  (E) NO INSURER PROVIDING COVERAGE UNDER THIS PARAGRAPH SHALL DISCRIMI-
NATE BASED ON A COVERED INDIVIDUAL'S EXPECTED LENGTH OF LIFE, PRESENT OR

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets

                      [ ] is old law to be omitted.
                                                           LBD01402-02-9

S. 719                              2

PREDICTED DISABILITY, DEGREE OF MEDICAL DEPENDENCY, PERCEIVED QUALITY OF
LIFE, OR OTHER HEALTH CONDITIONS, NOR BASED ON PERSONAL CHARACTERISTICS,
INCLUDING AGE, SEX, SEXUAL ORIENTATION, MARITAL STATUS OR GENDER IDENTI-
TY.
  §  2.  Paragraph  6 of subsection (k) of section 3221 of the insurance
law is amended by adding three new subparagraphs (E),  (F)  and  (G)  to
read as follows:
  (E)  EVERY GROUP POLICY DELIVERED OR ISSUED FOR DELIVERY IN THIS STATE
THAT PROVIDES HOSPITAL,  SURGICAL  OR  MEDICAL  COVERAGE  SHALL  PROVIDE
COVERAGE FOR:
  (I) IN VITRO FERTILIZATION USED IN THE TREATMENT OF INFERTILITY; AND
  (II) STANDARD FERTILITY PRESERVATION SERVICES WHEN A NECESSARY MEDICAL
TREATMENT  MAY  DIRECTLY OR INDIRECTLY CAUSE IATROGENIC INFERTILITY TO A
COVERED PERSON.
  (F) (I) FOR THE  PURPOSES  OF  SUBPARAGRAPH  (E)  OF  THIS  PARAGRAPH,
"INFERTILITY" MEANS A DISEASE OR CONDITION CHARACTERIZED BY THE INCAPAC-
ITY  TO IMPREGNATE ANOTHER PERSON OR TO CONCEIVE, AS DIAGNOSED OR DETER-
MINED (I) BY A PHYSICIAN LICENSED TO PRACTICE MEDICINE IN THIS STATE, OR
(II) BY THE FAILURE TO  ESTABLISH  A  CLINICAL  PREGNANCY  AFTER  TWELVE
MONTHS  OF  REGULAR, UNPROTECTED SEXUAL INTERCOURSE, OR AFTER SIX MONTHS
OF REGULAR, UNPROTECTED SEXUAL INTERCOURSE IN THE CASE OF A FEMALE THIR-
TY-FIVE YEARS OF AGE OR OLDER.
  (II) FOR THE PURPOSES OF SUBPARAGRAPH (E) OF THIS  PARAGRAPH,  "IATRO-
GENIC  INFERTILITY"  MEANS  AN IMPAIRMENT OF FERTILITY BY SURGERY, RADI-
ATION, CHEMOTHERAPY OR OTHER MEDICAL  TREATMENT  AFFECTING  REPRODUCTIVE
ORGANS OR PROCESSES.
  (G) NO INSURER PROVIDING COVERAGE UNDER THIS PARAGRAPH SHALL DISCRIMI-
NATE BASED ON A COVERED INDIVIDUAL'S EXPECTED LENGTH OF LIFE, PRESENT OR
PREDICTED DISABILITY, DEGREE OF MEDICAL DEPENDENCY, PERCEIVED QUALITY OF
LIFE, OR OTHER HEALTH CONDITIONS, NOR BASED ON PERSONAL CHARACTERISTICS,
INCLUDING AGE, SEX, SEXUAL ORIENTATION, MARITAL STATUS OR GENDER IDENTI-
TY.
  §  3.  Subsection (s) of section 4303 of the insurance law, as amended
by section 2 of part K of chapter 82 of the laws of 2002, is amended  by
adding three new paragraphs (5), (6) and (7) to read as follows:
  (5)  EVERY CONTRACT ISSUED BY A MEDICAL EXPENSE INDEMNITY CORPORATION,
HOSPITAL SERVICE CORPORATION OR HEALTH SERVICE CORPORATION FOR  DELIVERY
IN THIS STATE THAT PROVIDES HOSPITAL, SURGICAL OR MEDICAL COVERAGE SHALL
PROVIDE COVERAGE FOR:
  (A) IN VITRO FERTILIZATION USED IN THE TREATMENT OF INFERTILITY; AND
  (B)  STANDARD FERTILITY PRESERVATION SERVICES WHEN A NECESSARY MEDICAL
TREATMENT MAY DIRECTLY OR INDIRECTLY CAUSE IATROGENIC INFERTILITY  TO  A
COVERED PERSON.
  (6) (A) FOR THE PURPOSES OF PARAGRAPH FIVE OF THIS SUBSECTION, "INFER-
TILITY"  MEANS A DISEASE OR CONDITION CHARACTERIZED BY THE INCAPACITY TO
IMPREGNATE ANOTHER PERSON OR TO CONCEIVE, AS DIAGNOSED OR DETERMINED (I)
BY A PHYSICIAN LICENSED TO PRACTICE MEDICINE IN THIS STATE, OR  (II)  BY
THE  FAILURE  TO  ESTABLISH  A CLINICAL PREGNANCY AFTER TWELVE MONTHS OF
REGULAR, UNPROTECTED SEXUAL INTERCOURSE, OR AFTER SIX MONTHS OF REGULAR,
UNPROTECTED SEXUAL INTERCOURSE IN THE CASE OF A FEMALE THIRTY-FIVE YEARS
OF AGE OR OLDER.
  (B) FOR THE PURPOSES OF PARAGRAPH FIVE OF THIS SUBSECTION, "IATROGENIC
INFERTILITY" MEANS AN IMPAIRMENT OF  FERTILITY  BY  SURGERY,  RADIATION,
CHEMOTHERAPY OR OTHER MEDICAL TREATMENT AFFECTING REPRODUCTIVE ORGANS OR
PROCESSES.

S. 719                              3

  (7)  NO MEDICAL EXPENSE INDEMNITY CORPORATION, HOSPITAL SERVICE CORPO-
RATION OR HEALTH  SERVICE  CORPORATION  PROVIDING  COVERAGE  UNDER  THIS
SUBSECTION  SHALL  DISCRIMINATE BASED ON A COVERED INDIVIDUAL'S EXPECTED
LENGTH OF LIFE, PRESENT  OR  PREDICTED  DISABILITY,  DEGREE  OF  MEDICAL
DEPENDENCY,  PERCEIVED  QUALITY OF LIFE, OR OTHER HEALTH CONDITIONS, NOR
BASED ON PERSONAL CHARACTERISTICS, INCLUDING  AGE,  SEX,  SEXUAL  ORIEN-
TATION, MARITAL STATUS OR GENDER IDENTITY.
  § 4. Subparagraph (C) of paragraph 6 of subsection (k) of section 3221
of the insurance law, as amended by section 1 of part K of chapter 82 of
the laws of 2002, is amended to read as follows:
  (C)   Coverage  of  diagnostic  and  treatment  procedures,  including
prescription drugs, used in the diagnosis and treatment  of  infertility
as  required  by  subparagraphs  (A)  and (B) of this paragraph shall be
provided in accordance with the provisions of this subparagraph.
  (i) [Coverage shall be provided for  persons  whose  ages  range  from
twenty-one  through forty-four years, provided that nothing herein shall
preclude the provision of coverage to persons  whose  age  is  below  or
above such range.
  (ii)]  Diagnosis  and  treatment of infertility shall be prescribed as
part of a physician's overall plan  of  care  and  consistent  with  the
guidelines for coverage as referenced in this subparagraph.
  [(iii)]  (II)  Coverage may be subject to co-payments, coinsurance and
deductibles as may be deemed appropriate by the  superintendent  and  as
are  consistent with those established for other benefits within a given
policy.
  [(iv) Coverage shall be limited to those  individuals  who  have  been
previously covered under the policy for a period of not less than twelve
months,  provided  that for the purposes of this subparagraph "period of
not less than twelve months" shall be  determined  by  calculating  such
time from either the date the insured was first covered under the exist-
ing policy or from the date the insured was first covered by a previous-
ly in-force converted policy, whichever is earlier.
  (v)] (III) Coverage shall not be required to include the diagnosis and
treatment  of  infertility  in connection with: (I) [in vitro fertiliza-
tion, gamete intrafallopian tube transfers or zygote intrafallopian tube
transfers; (II)] the reversal of elective sterilizations;  [(III)]  (II)
sex  change  procedures;  [(IV)] (III) cloning; or [(V)] (IV) medical or
surgical services or procedures that are deemed to  be  experimental  in
accordance  with clinical guidelines referenced in clause [(vi)] (IV) of
this subparagraph.
  [(vi)] (IV) The superintendent, in consultation with the  commissioner
of health, shall promulgate regulations which shall stipulate the guide-
lines  and  standards which shall be used in carrying out the provisions
of this subparagraph, which shall include:
  (I) [The determination of "infertility" in accordance with the  stand-
ards  and  guidelines established and adopted by the American College of
Obstetricians and Gynecologists and the American Society  for  Reproduc-
tive Medicine;
  (II)] The identification of experimental procedures and treatments not
covered  for  the  diagnosis  and treatment of infertility determined in
accordance with the standards and guidelines established and adopted  by
the American College of Obstetricians and Gynecologists and the American
Society for Reproductive Medicine;
  [(III)]  (II)  The identification of the required training, experience
and other standards for health  care  providers  for  the  provision  of
procedures and treatments for the diagnosis and treatment of infertility

S. 719                              4

determined  in  accordance with the standards and guidelines established
and adopted by the American College of Obstetricians  and  Gynecologists
and the American Society for Reproductive Medicine; and
  [(IV)]  (III)  The  determination of appropriate medical candidates by
the treating physician in accordance with the standards  and  guidelines
established  and  adopted  by  the American College of Obstetricians and
Gynecologists and/or the American Society for Reproductive Medicine.
  § 5. Paragraph 3 of subsection (s) of section 4303  of  the  insurance
law,  as  amended  by  section  2 of part K of chapter 82 of the laws of
2002, is amended to read as follows:
  (3)  Coverage  of  diagnostic  and  treatment  procedures,   including
prescription drugs used in the diagnosis and treatment of infertility as
required  by paragraphs one and two of this subsection shall be provided
in accordance with this paragraph.
  (A) [Coverage shall be provided for  persons  whose  ages  range  from
twenty-one  through forty-four years, provided that nothing herein shall
preclude the provision of coverage to persons  whose  age  is  below  or
above such range.
  (B)]  Diagnosis  and  treatment  of infertility shall be prescribed as
part of a physician's overall plan  of  care  and  consistent  with  the
guidelines for coverage as referenced in this paragraph.
  [(C)]  (B)  Coverage  may  be  subject to co-payments, coinsurance and
deductibles as may be deemed appropriate by the  superintendent  and  as
are  consistent with those established for other benefits within a given
policy.
  [(D) Coverage shall be limited to  those  individuals  who  have  been
previously covered under the policy for a period of not less than twelve
months,  provided that for the purposes of this paragraph "period of not
less than twelve months" shall be determined by  calculating  such  time
from  either  the  date the insured was first covered under the existing
policy or from the date the insured was first covered  by  a  previously
in-force converted policy, whichever is earlier.
  (E)]  (C)  Coverage shall not be required to include the diagnosis and
treatment of infertility in connection with: (i)  [in  vitro  fertiliza-
tion, gamete intrafallopian tube transfers or zygote intrafallopian tube
transfers;  (ii)]  the reversal of elective sterilizations; [(iii)] (II)
sex change procedures; [(iv)] (III) cloning; or [(v)]  (IV)  medical  or
surgical  services  or  procedures that are deemed to be experimental in
accordance with clinical guidelines referenced in subparagraph [(F)] (D)
of this paragraph.
  [(F)] (D) The superintendent, in consultation with the commissioner of
health, shall promulgate regulations which shall  stipulate  the  guide-
lines  and  standards which shall be used in carrying out the provisions
of this paragraph, which shall include:
  (i) [The determination of "infertility" in accordance with the  stand-
ards  and  guidelines established and adopted by the American College of
Obstetricians and Gynecologists and the American Society  for  Reproduc-
tive Medicine;
  (ii)] The identification of experimental procedures and treatments not
covered  for  the  diagnosis  and treatment of infertility determined in
accordance with the standards and guidelines established and adopted  by
the American College of Obstetricians and Gynecologists and the American
Society for Reproductive Medicine;
  [(iii)]  (II)  The identification of the required training, experience
and other standards for health  care  providers  for  the  provision  of
procedures and treatments for the diagnosis and treatment of infertility

S. 719                              5

determined  in  accordance with the standards and guidelines established
and adopted by the American College of Obstetricians  and  Gynecologists
and the American Society for Reproductive Medicine; and
  [(iv)]  (III)  The  determination of appropriate medical candidates by
the treating physician in accordance with the standards  and  guidelines
established  and  adopted  by  the American College of Obstetricians and
Gynecologists and/or the American Society for Reproductive Medicine.
  § 6. This act shall take effect on  the  first  day  of  January  next
succeeding  the date on which it shall have become a law and shall apply
to all policies issued, renewed, altered or modified on  or  after  such
date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

The New York State Senate

senate Bill S719

Sponsored By

Archive: Last Bill Status - In Senate Committee Insurance Committee

Your Voice

Actions

Co-Sponsors

S719 (ACTIVE) - Details

S719 (ACTIVE) - Summary

S719 (ACTIVE) - Sponsor Memo

S719 (ACTIVE) - Bill Text download pdf

Comments

senate Bill S719

Share this bill

Sponsored By

Archive: Last Bill Status - In Senate Committee Insurance Committee

Your Voice

Actions

Co-Sponsors

S719 (ACTIVE) - Details

S719 (ACTIVE) - Summary

S719 (ACTIVE) - Sponsor Memo

S719 (ACTIVE) - Bill Text download pdf

Comments